Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early ...

Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...

Illumina, Commercial Metals and Newmont stand out as brokers boost ratings amid inflation concerns and shifting economic signals.

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

Quest Diagnostics appoints new leader for Blueprint. Juhana Rauramo is in as vice president and general manager for Blueprint ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

Mr. Nyhan is a political scientist at Dartmouth College and a co-director of Bright Line Watch, which monitors the status of American democracy. The second Trump administration is already breaking ...

Next Gen Stats continues to evolve how we can quantify what we see on Sundays (and Mondays, Thursdays, an occasional Friday or Saturday and some other days). Senior NFL Researcher Tony ...

Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series ...